Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
zebrafish |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Oncostatin-M is a cytokine produced by activated lymphoid cells that regulates the proliferation of a number of tumour cell lines. It may play a role in the pathogenesis of AIDS-KS []. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
263
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang X |
Year: |
2015 |
Journal: |
Biomed Res Int |
Title: |
OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction. |
Volume: |
2015 |
|
Pages: |
317905 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu J |
Year: |
2017 |
Journal: |
Biochim Biophys Acta |
Title: |
OSM mitigates post-infarction cardiac remodeling and dysfunction by up-regulating autophagy through Mst1 suppression. |
Volume: |
1863 |
Issue: |
8 |
Pages: |
1951-1961 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tanaka M |
Year: |
1999 |
Journal: |
Blood |
Title: |
Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit. |
Volume: |
93 |
Issue: |
3 |
Pages: |
804-15 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
99
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Miles SA |
Year: |
1992 |
Journal: |
Science |
Title: |
Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. |
Volume: |
255 |
Issue: |
5050 |
Pages: |
1432-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Esashi E |
Year: |
2009 |
Journal: |
Eur J Immunol |
Title: |
Oncostatin M deficiency leads to thymic hypoplasia, accumulation of apoptotic thymocytes and glomerulonephritis. |
Volume: |
39 |
Issue: |
6 |
Pages: |
1664-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mukouyama Y |
Year: |
1998 |
Journal: |
Immunity |
Title: |
In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region. |
Volume: |
8 |
Issue: |
1 |
Pages: |
105-14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hara T |
Year: |
1998 |
Journal: |
Dev Biol |
Title: |
Distinct roles of oncostatin M and leukemia inhibitory factor in the development of primordial germ cells and sertoli cells in mice. |
Volume: |
201 |
Issue: |
2 |
Pages: |
144-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kubin T |
Year: |
2011 |
Journal: |
Cell Stem Cell |
Title: |
Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. |
Volume: |
9 |
Issue: |
5 |
Pages: |
420-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Keulen DV |
Year: |
2019 |
Journal: |
PLoS One |
Title: |
Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans. |
Volume: |
14 |
Issue: |
8 |
Pages: |
e0221477 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rose TM |
Year: |
1994 |
Journal: |
Cytokine |
Title: |
Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro. |
Volume: |
6 |
Issue: |
1 |
Pages: |
48-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Weiss TW |
Year: |
2006 |
Journal: |
FASEB J |
Title: |
Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo. |
Volume: |
20 |
Issue: |
13 |
Pages: |
2369-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sugaya M |
Year: |
2006 |
Journal: |
J Immunol |
Title: |
Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes. |
Volume: |
177 |
Issue: |
11 |
Pages: |
7665-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Brounais B |
Year: |
2009 |
Journal: |
Bone |
Title: |
Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells. |
Volume: |
44 |
Issue: |
5 |
Pages: |
830-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jung ID |
Year: |
2010 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Oncostatin M induces dendritic cell maturation and Th1 polarization. |
Volume: |
394 |
Issue: |
2 |
Pages: |
272-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Drechsler J |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Characterization of the rat oncostatin M receptor complex which resembles the human, but differs from the murine cytokine receptor. |
Volume: |
7 |
Issue: |
8 |
Pages: |
e43155 |
|
•
•
•
•
•
|
Publication |
First Author: |
Adrian-Segarra JM |
Year: |
2018 |
Journal: |
J Biol Chem |
Title: |
The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice. |
Volume: |
293 |
Issue: |
52 |
Pages: |
20181-20199 |
|
•
•
•
•
•
|
Publication |
First Author: |
Setiadi H |
Year: |
2019 |
Journal: |
Blood Adv |
Title: |
Endothelial signaling by neutrophil-released oncostatin M enhances P-selectin-dependent inflammation and thrombosis. |
Volume: |
3 |
Issue: |
2 |
Pages: |
168-183 |
|
•
•
•
•
•
|
Publication |
First Author: |
Machiyama T |
Year: |
2018 |
Journal: |
Biochem Biophys Res Commun |
Title: |
TNF receptor associated factor 5 controls oncostatin M-mediated lung inflammation. |
Volume: |
499 |
Issue: |
3 |
Pages: |
544-550 |
|
•
•
•
•
•
|
Publication |
First Author: |
Beatus P |
Year: |
2011 |
Journal: |
Dev Neurobiol |
Title: |
Oncostatin M regulates neural precursor activity in the adult brain. |
Volume: |
71 |
Issue: |
7 |
Pages: |
619-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee BY |
Year: |
2021 |
Journal: |
Nat Commun |
Title: |
Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis. |
Volume: |
12 |
Issue: |
1 |
Pages: |
7336 |
|
•
•
•
•
•
|
Publication |
First Author: |
Son HJ |
Year: |
2017 |
Journal: |
J Immunol |
Title: |
Oncostatin M Suppresses Activation of IL-17/Th17 via SOCS3 Regulation in CD4+ T Cells. |
Volume: |
198 |
Issue: |
4 |
Pages: |
1484-1491 |
|
•
•
•
•
•
|
Publication |
First Author: |
Langeslag M |
Year: |
2011 |
Journal: |
Mol Pain |
Title: |
Oncostatin M induces heat hypersensitivity by gp130-dependent sensitization of TRPV1 in sensory neurons. |
Volume: |
7 |
|
Pages: |
102 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang X |
Year: |
2016 |
Journal: |
Acta Biochim Biophys Sin (Shanghai) |
Title: |
Oncostatin M-induced cardiomyocyte dedifferentiation regulates the progression of diabetic cardiomyopathy through B-Raf/Mek/Erk signaling pathway. |
Volume: |
48 |
Issue: |
3 |
Pages: |
257-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tedesco S |
Year: |
2020 |
Journal: |
Diabetes |
Title: |
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes. |
Volume: |
69 |
Issue: |
7 |
Pages: |
1562-1572 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fritz DK |
Year: |
2011 |
Journal: |
J Immunol |
Title: |
A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent. |
Volume: |
186 |
Issue: |
2 |
Pages: |
1107-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Headland SE |
Year: |
2022 |
Journal: |
Sci Transl Med |
Title: |
Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma. |
Volume: |
14 |
Issue: |
627 |
Pages: |
eabf8188 |
|
•
•
•
•
•
|
Publication |
First Author: |
Araujo AM |
Year: |
2022 |
Journal: |
J Clin Invest |
Title: |
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. |
Volume: |
132 |
Issue: |
7 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Walker EC |
Year: |
2010 |
Journal: |
J Clin Invest |
Title: |
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. |
Volume: |
120 |
Issue: |
2 |
Pages: |
582-92 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guihard P |
Year: |
2015 |
Journal: |
Am J Pathol |
Title: |
Oncostatin m, an inflammatory cytokine produced by macrophages, supports intramembranous bone healing in a mouse model of tibia injury. |
Volume: |
185 |
Issue: |
3 |
Pages: |
765-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hermans D |
Year: |
2022 |
Journal: |
Acta Neuropathol |
Title: |
Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrity. |
Volume: |
144 |
Issue: |
2 |
Pages: |
259-281 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sato F |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Oncostatin M maintains the hematopoietic microenvironment in the bone marrow by modulating adipogenesis and osteogenesis. |
Volume: |
9 |
Issue: |
12 |
Pages: |
e116209 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pohin M |
Year: |
2016 |
Journal: |
Eur J Immunol |
Title: |
Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation. |
Volume: |
46 |
Issue: |
7 |
Pages: |
1737-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Elks CM |
Year: |
2016 |
Journal: |
J Biol Chem |
Title: |
Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo. |
Volume: |
291 |
Issue: |
33 |
Pages: |
17066-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
West NR |
Year: |
2017 |
Journal: |
Nat Med |
Title: |
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. |
Volume: |
23 |
Issue: |
5 |
Pages: |
579-589 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kamiya A |
Year: |
2001 |
Journal: |
FEBS Lett |
Title: |
Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways. |
Volume: |
492 |
Issue: |
1-2 |
Pages: |
90-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Abe H |
Year: |
2019 |
Journal: |
Nat Commun |
Title: |
Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M. |
Volume: |
10 |
Issue: |
1 |
Pages: |
2824 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang G |
Year: |
2024 |
Journal: |
Immunity |
Title: |
Adipose-tissue Treg cells restrain differentiation of stromal adipocyte precursors to promote insulin sensitivity and metabolic homeostasis. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Sampath SC |
Year: |
2018 |
Journal: |
Nat Commun |
Title: |
Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin M. |
Volume: |
9 |
Issue: |
1 |
Pages: |
1531 |
|
•
•
•
•
•
|
Publication |
First Author: |
Botelho FM |
Year: |
2013 |
Journal: |
J Immunol |
Title: |
Pulmonary expression of oncostatin M (OSM) promotes inducible BALT formation independently of IL-6, despite a role for IL-6 in OSM-driven pulmonary inflammation. |
Volume: |
191 |
Issue: |
3 |
Pages: |
1453-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Morikawa Y |
Year: |
2004 |
Journal: |
J Neurosci |
Title: |
Essential function of oncostatin m in nociceptive neurons of dorsal root ganglia. |
Volume: |
24 |
Issue: |
8 |
Pages: |
1941-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang M |
Year: |
2015 |
Journal: |
Apoptosis |
Title: |
Notch3/Akt signaling contributes to OSM-induced protection against cardiac ischemia/reperfusion injury. |
Volume: |
20 |
Issue: |
9 |
Pages: |
1150-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Richards CD |
Year: |
1997 |
Journal: |
J Immunol |
Title: |
Regulation of tissue inhibitor of metalloproteinase-1 in fibroblasts and acute phase proteins in hepatocytes in vitro by mouse oncostatin M, cardiotrophin-1, and IL-6. |
Volume: |
159 |
Issue: |
5 |
Pages: |
2431-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tiffen PG |
Year: |
2008 |
Journal: |
Mol Endocrinol |
Title: |
A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo. |
Volume: |
22 |
Issue: |
12 |
Pages: |
2677-88 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tamura S |
Year: |
2002 |
Journal: |
Dev Dyn |
Title: |
Expression of oncostatin M in hematopoietic organs. |
Volume: |
225 |
Issue: |
3 |
Pages: |
327-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Baker BJ |
Year: |
2010 |
Journal: |
Glia |
Title: |
IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia. |
Volume: |
58 |
Issue: |
9 |
Pages: |
1082-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bando T |
Year: |
2006 |
Journal: |
Neuroscience |
Title: |
Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns. |
Volume: |
142 |
Issue: |
4 |
Pages: |
1263-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang ECE |
Year: |
2019 |
Journal: |
Cell Stem Cell |
Title: |
A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth. |
Volume: |
24 |
Issue: |
4 |
Pages: |
654-669.e6 |
|
•
•
•
•
•
|
GO Term |
|
•
•
•
•
•
|
Publication |
First Author: |
Ho L |
Year: |
2020 |
Journal: |
Cells |
Title: |
RELMα is Induced in Airway Epithelial Cells by Oncostatin M Without Requirement of STAT6 or IL-6 in Mouse Lungs In Vivo. |
Volume: |
9 |
Issue: |
6 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Auernhammer CJ |
Year: |
2004 |
Journal: |
J Endocrinol |
Title: |
The oncostatin M receptor/gp130 ligand murine oncostatin M induces apoptosis in adrenocortical Y-1 tumor cells. |
Volume: |
180 |
Issue: |
3 |
Pages: |
479-86 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hsu MP |
Year: |
2015 |
Journal: |
Glia |
Title: |
Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M. |
Volume: |
63 |
Issue: |
1 |
Pages: |
132-41 |
|
•
•
•
•
•
|
Publication |
First Author: |
van Krieken PP |
Year: |
2021 |
Journal: |
Mol Metab |
Title: |
Oncostatin M suppresses browning of white adipocytes via gp130-STAT3 signaling. |
Volume: |
54 |
|
Pages: |
101341 |
|
•
•
•
•
•
|
Publication |
First Author: |
Smyth DC |
Year: |
2006 |
Journal: |
J Immunol |
Title: |
Oncostatin M-induced IL-6 expression in murine fibroblasts requires the activation of protein kinase Cdelta. |
Volume: |
177 |
Issue: |
12 |
Pages: |
8740-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hintzen C |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
Oncostatin M-induced and constitutive activation of the JAK2/STAT5/CIS pathway suppresses CCL1, but not CCL7 and CCL8, chemokine expression. |
Volume: |
181 |
Issue: |
10 |
Pages: |
7341-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wong S |
Year: |
2014 |
Journal: |
Lab Invest |
Title: |
Oncostatin M overexpression induces matrix deposition, STAT3 activation, and SMAD1 Dysregulation in lungs of fibrosis-resistant BALB/c mice. |
Volume: |
94 |
Issue: |
9 |
Pages: |
1003-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fritz DK |
Year: |
2006 |
Journal: |
J Immunol |
Title: |
Oncostatin-M up-regulates VCAM-1 and synergizes with IL-4 in eotaxin expression: involvement of STAT6. |
Volume: |
176 |
Issue: |
7 |
Pages: |
4352-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fritz DK |
Year: |
2009 |
Journal: |
Exp Cell Res |
Title: |
Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1. |
Volume: |
315 |
Issue: |
20 |
Pages: |
3486-99 |
|
•
•
•
•
•
|
Publication |
First Author: |
Walker EC |
Year: |
2016 |
Journal: |
J Biol Chem |
Title: |
Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass. |
Volume: |
291 |
Issue: |
41 |
Pages: |
21703-21716 |
|
•
•
•
•
•
|
Publication |
First Author: |
Piquet-Pellorce C |
Year: |
1994 |
Journal: |
Exp Cell Res |
Title: |
Are LIF and related cytokines functionally equivalent? |
Volume: |
213 |
Issue: |
2 |
Pages: |
340-7 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus pahari |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus spretus |
|
•
•
•
•
•
|
Publication |
First Author: |
Botelho FM |
Year: |
2019 |
Journal: |
Cells |
Title: |
Extracellular Matrix and Fibrocyte Accumulation in BALB/c Mouse Lung upon Transient Overexpression of Oncostatin M. |
Volume: |
8 |
Issue: |
2 |
|
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2451085 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-03-12 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1797220 |
|
Stage: |
TS20 |
Assay Id: |
MGI:2451096 |
Age: |
embryonic day 12.5 |
|
|
Specimen Label: |
12.5, male |
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2451085 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-03-12 |
Strength: |
Present |
Sex: |
Female |
Emaps: |
EMAPS:1796220 |
|
Stage: |
TS20 |
Assay Id: |
MGI:2451096 |
Age: |
embryonic day 12.5 |
|
|
Specimen Label: |
12.5, female |
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2451085 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-03-12 |
Strength: |
Present |
Sex: |
Male |
Emaps: |
EMAPS:1797221 |
|
Stage: |
TS21 |
Assay Id: |
MGI:2451096 |
Age: |
embryonic day 13.5 |
|
|
Specimen Label: |
13.5, male |
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2451085 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-03-12 |
Strength: |
Present |
Sex: |
Female |
Emaps: |
EMAPS:1796221 |
|
Stage: |
TS21 |
Assay Id: |
MGI:2451096 |
Age: |
embryonic day 13.5 |
|
|
Specimen Label: |
13.5, female |
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2451085 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-03-12 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1684622 |
|
Stage: |
TS22 |
Assay Id: |
MGI:2451120 |
Age: |
embryonic day 14.0 |
|
|
Specimen Label: |
E14, 35 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2451085 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-03-12 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1684622 |
|
Stage: |
TS22 |
Assay Id: |
MGI:2451120 |
Age: |
embryonic day 14.0 |
|
|
Specimen Label: |
E14, 40 |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2451085 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-03-12 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1684626 |
|
Stage: |
TS26 |
Assay Id: |
MGI:2451120 |
Age: |
embryonic day 18.0 |
|
|
Specimen Label: |
E18, 35 |
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2451085 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-03-12 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1684626 |
|
Stage: |
TS26 |
Assay Id: |
MGI:2451120 |
Age: |
embryonic day 18.0 |
|
|
Specimen Label: |
E18, 40 |
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2451085 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-03-12 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1684627 |
|
Stage: |
TS27 |
Assay Id: |
MGI:2451120 |
Age: |
postnatal newborn |
|
|
Specimen Label: |
neonatal, 35 |
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2451085 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-03-12 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1684627 |
|
Stage: |
TS27 |
Assay Id: |
MGI:2451120 |
Age: |
postnatal newborn |
|
|
Specimen Label: |
neonatal, 40 |
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|